Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Nokia Corporation (ADR) (NOK), Ericsson (ADR) (ERIC): There Was No Stopping the OMX Stockholm 30 Last Week

Could the OMX Stockholm 30 Index (INDEXNASDAQ:OMXS30) notch another week of gains after Nokia Corporation (ADR) (NYSE:NOK)‘s big deal with Microsoft helped push it up last week? In short: yes.

The week ended on a somewhat somber note for Sweden as the initial estimate for GDP contraction during the second quarter was revised up to 0.2%. The economic drop was driven by lower fixed capital investments and exports. If there was a bright spot, it was that household consumption still climbed 1.9% during the quarter.

Nokia Corporation (ADR) (NYSE:NOK)But if the economic news was sour, somebody forgot to tell that to the main market index as the OMX Stockholm 30 rose 1.4% for the week. Once again, Nokia Corporation (ADR) (NYSE:NOK) was the index’s biggest gainer, tacking on 15%. Investors unsure what the company will look like now that it’s sold the mobile division to Microsoft are apparently getting more comfortable with the outlook for the future.

Ericsson (ADR) (NASDAQ:ERIC), meanwhile, which benefited from Nokia Corporation (ADR) (NYSE:NOK)’s stock market tailwind last week, saw its stock on the rise again this week, tacking on nearly 3%. On Thursday, the company found itself on the right side of a Goldman Sachs thumbs up as the investment bank added Ericsson (ADR) (NASDAQ:ERIC) to its “conviction buy” list.

Bulking up
Industrial equipment giant Atlas Copco AB was also among the index’s big gainers as it added 4.5%. After the big bite that Atlas made last month when it acquired Edwards Group , the company showed this week that it will keep right on growing — albeit in smaller increments for now.

Atlas announced two acquisitions this week. On Monday, it announced the purchase of the 16-employee Turkish compressor sales and services company Dost Kompresor. Atlas followed up on Tuesday by buying U.S.-based Pneumatic Holdings, a provider of construction tools.

To cap a positive week, Atlas was once again named part of the Dow Jones Sustainability Index. This is another feather in the cap of a company that’s been widely recognized for its sustainability efforts. Earlier this year, Atlas was honored as one of the world’s most ethical companies by Ethisphere.

The Nomura knockdown
Though most of the stocks in Sweden’s key index were in the black for the week, steelmaker SSAB AB was well in the red. Even with the stock down double digits year to date, the analysts at Nomura decided that it was still a bit too rich for their taste and downgraded the shares from “neutral” to “reduce.”

Per Bloomberg, Nomura wrote to clients that:

Not only does SSAB require one of the largest earnings recoveries in 2014 to sustain its current valuation, it will have a relatively limited impact from its cost-saving program — completed in the first quarter 2013 — and will no longer benefit from below-spot iron ore prices, as it has done in the first half 2013.

According to Nomura, the stock’s current valuation of 10 times forward earnings estimates is above the eight-times multiple on other companies in the industry.

The article There Was No Stopping the OMX Stockholm 30 This Week originally appeared on and is written by Matt Koppenheffer.

Matt Koppenheffer owns shares of Goldman Sachs. The Motley Fool recommends Goldman Sachs. The Motley Fool owns shares of Microsoft.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!